Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis

详细信息    查看全文

• 作者：Guohua Shen ; Zhiyun Jia ; Houfu Deng
• 关键词：Diffusion ; weighted imaging ; Magnetic resonance imaging ; Pulmonary lesions ; ADC value ; Differentiation
• 刊名：European Radiology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：26
• 期：2
• 页码：556-566
• 全文大小：652 KB
• 参考文献：1.Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29PubMed CrossRef
  2.Stupp R, Monnerat C, Turrisi AT 3rd, Perry MC, Leyvraz S (2004) Small cell lung cancer: state of the art and future perspectives. Lung Cancer 45:105–117PubMed CrossRef
  3.Kim HS, Lee KS, Ohno Y, van Beek EJ, Biederer J (2014) PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer. J Magn Reson Imaging. doi:10.​1002/​jmri.​24776
  4.Jeong YJ, Lee KS, Jeong SY et al (2005) Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT. Radiology 237:675–683PubMed CrossRef
  5.Henschke CI, Yankelevitz DF, Naidich DP et al (2004) CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 231:164–168PubMed CrossRef
  6.Uto T, Takehara Y, Nakamura Y et al (2009) Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 252:247–254PubMed CrossRef
  7.Cheran SK, Nielsen ND, Patz EF Jr (2004) False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol 182:1129–1132PubMed CrossRef
  8.Shim SS, Lee KS, Kim BT, Choi JY, Chung MJ, Lee EJ (2006) Focal parenchymal lung lesions showing a potential of false-positive and false-negative interpretations on integrated PET/CT. AJR Am J Roentgenol 186:639–648PubMed CrossRef
  9.Mori T, Nomori H, Ikeda K et al (2008) Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses - Comparison with positron emission tomography. J Thorac Oncol 3:358–364PubMed CrossRef
  10.Ohno Y, Koyama H, Onishi Y et al (2008) Non-small cell lung cancer: Whole-body MR examination for M-stage assessment - Utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 248:643–654PubMed CrossRef
  11.Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S, Endo Y (2008) Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol 191:464–470PubMed CrossRef
  12.Regier M, Schwarz D, Henes FO et al (2011) Diffusion-weighted MR-imaging for the detection of pulmonary nodules at 1.5 Tesla: Intraindividual comparison with multidetector computed tomography. J Med Imaging Radiat Oncol 55:266–274PubMed CrossRef
  13.Chen L, Zhang J, Chen Y et al (2014) Relationship between apparent diffusion coefficient and tumour cellularity in lung cancer. PLoS One 9:e99865PubMed PubMedCentral CrossRef
  14.Yabuuchi H, Hatakenaka M, Takayama K et al (2011) Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging. Radiology 261:598–604PubMed CrossRef
  15.Chang Q, Wu N, Ouyang H, Huang Y (2012) Diffusion-weighted magnetic resonance imaging of lung cancer at 3.0 T: a preliminary study on monitoring diffusion changes during chemoradiation therapy. Clin Imaging 36:98–103PubMed CrossRef
  16.Wu LM, Xu JR, Hua J et al (2013) Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses? Magn Reson Imaging 31:235–246PubMed CrossRef
  17.Chen L, Zhang J, Bao J et al (2013) Meta-analysis of diffusion-weighted MRI in the differential diagnosis of lung lesions. J Magn Reson Imaging 37:1351–1358PubMed CrossRef
  18.Wang M, Zhang W, Zhang N et al (2011) Diagnostic value of 3.0T magnetic resonance diffusion-weighted imaging in benign and malignant lung tumors. Acta Acad Med Jiangxi 51:14–19
  19.Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6:9PubMed PubMedCentral CrossRef
  20.Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMed CrossRef
  21.Zhao X, Yao J (2011) The role of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient on histologic diagnosis of lung cancer. J China Med Univ 40:449–451
  22.Liu Z, Li C, Chen J et al (2008) Correlation between magnetic resonance diffusion-weighted imaging and cellular density in lung caner. BME Clin Med 12:474–477
  23.Liu H, Zeng L, Wang A et al (2014) Preliminary study in differentiation of postobstructive consolidation from central lung carcinoma at 3.0T MRI. J Pract Radiol 30:1306–1309
  24.Li W, Yu T, Xu K, Li D (2013) 3.0T MR diffusion-weighted imaging in diagnosis of pulmonary solid lesions: comparing with patholody. J Pract Radiol 29:1757–1761
  25.Li F, Huang X, Qian H (2013) MR-DWI and ADC values for evaluating the effect of radiotherapy for early stage lung cancer. J Med Imagin 23:702–706
  26.Kang H, Zhang W, Jin R, Chen J (2011) Comparison of whole-body diffusion-weighted magnetic resonance imaging and positron emission tomography in lung cancer. Radio Pract 26:286–289
  27.Dong H, Jiang R, Fang W, Ma Z, Zhou M, Zhang W (2011) Diagnostic value of diffusion-weighted MR imaging and CT-guided biopsy in pulmonary benign and malignant lesion. J Chin Clin Med Imaging 22:268–271
  28.Deng Q, Qiu W, Zhang P, Xu L, Wang X (2012) The value on distinguishing pulmonary malignant tumors from benign lesions by diffusion-weighted imaging. Chin J CT MRI 10:35–37
  29.Chen G, Qu C, Zheng T et al (2013) Differentiation of pulmonary benign and malignant lesions with diffusion-weighted MR imaging. Radiol Pract 28:763–766
  30.Cai C, Zhao S, Lin L (2011) The value of MR diffusion weilghted imaging with STIR-EPI sequence for differentiating benign from malignant pulmonary nodules. J Pract Med Imaging 12:358–361
  31.Zhang J, Cui LB, Tang X et al (2014) DW MRI at 3.0 T versus FDG PET/CT for detection of malignant pulmonary tumors. Int J Cancer 134:606–611PubMed CrossRef
  32.Yang R-M, Li L, Wei X-H et al (2013) Differentiation of Central Lung Cancer from Atelectasis: Comparison of Diffusion-Weighted MRI with PET/CT. PLoS One 8:e60279PubMed PubMedCentral CrossRef
  33.H-w W, Cheng J-j X, J-r LQ, Ge X, Li L (2008) The preliminary study of MR diffusion weighted imaging with background body signal suppression on pulmonary diseases. Chin J Radiol 42:56–59
  34.Wang LL, Lin J, Liu K et al (2014) Intravoxel incoherent motion diffusion-weighted MR imaging in differentiation of lung cancer from obstructive lung consolidation: comparison and correlation with pharmacokinetic analysis from dynamic contrast-enhanced MR imaging. Eur Radiol 24:1914–1922PubMed CrossRef
  35.Usuda K, Zhao XT, Sagawa M et al (2011) Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers. Ann Thorac Surg 91:1689–1695PubMed CrossRef
  36.Usuda K, Sagawa M, Motono N et al (2014) Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses: comparison with positron emission tomography. Asian Pac J Cancer P 15:4629–4635CrossRef
  37.Tondo F, Saponaro A, Stecco A, Lombardi M, Casadio C, Carriero A (2011) Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum. Radiol Med 116:720–733PubMed CrossRef
  38.Razek AA, Fathy A, Gawad TA (2011) Correlation of apparent diffusion coefficient value with prognostic parameters of lung cancer. J Comput Assist Tomogr 35:248–252PubMed CrossRef
  39.Qi LP, Zhang XP, Tang L, Sun YS, Wang N (2007) Diffusion-weighted MR imaging for differentiation diagnosis of central lung cancer from postobstructive lobar collapse-preliminary study. Chin J Med Imaging Technol 23:1486–1490
  40.Matoba M, Tonami H, Kondou T et al (2007) Lung carcinoma: diffusion-weighted MR imaging - preliminary evaluation with apparent diffusion coefficient. Radiology 243:570–577PubMed CrossRef
  41.Li Z, Zhang T, Xu B et al (2010) Usefulness of DWI in the evaluation of pulmonary isolated lesions. Chinese-German J Clin Oncol 9:388–390CrossRef
  42.Li W, Li D, Liu H et al (2011) 3.0T MR diffusion-weighted imaging: evaluating diagnosis potency of pulmonary solid benign lesions and malignant tumors and optimizing b value. Chin J Lung Cancer 14:853–857
  43.Li F, Yu T, Li W et al (2012) Correlation of apparent diffusion coefficient with histologic type and grade of lung cancer. J Med Imaging 23:702–706
  44.Koyama H, Ohno Y, Nishio M et al (2014) Diffusion-weighted imaging vs STIR turbo SE imaging: capability for quantitative differentiation of small-cell lung cancer from non-small-cell lung cancer. Br J Radiol 87:20130307PubMed PubMedCentral CrossRef
  45.Koyama H, Ohno Y, Aoyama N et al (2010) Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas. Eur Radiol 20:790–800PubMed CrossRef
  46.Haidong L, Ying L, Tielian Y, Ning Y (2010) Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol 20:807–815CrossRef
  47.Gumustas S, Inan N, Akansel G, Ciftci E, Demirci A, Ozkara SK (2012) Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging. Radiol Oncol 46:106–113PubMed PubMedCentral CrossRef
  48.Deng QM, Qiu WJ, Zhou ZP, Shi ZS, Wang XF (2012) Value of b value in differential diagnosis of benign and malignant lung lesions with DWI. Chin J Med Imaging Technol 28:1537–1540
  49.Chen LH, Chen YF, Zhang JQ, Wang WW, Xia YB, Wang J (2012) Application value of apparent diffusion coefficient in diagnosis of different histological subtypes of lung cancers. Chin J Med Imaging Technol 28:1541–1545
  50.Bernardin L, Douglas N, Collins D et al (2014) Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement. Eur Radiol 24:502–511PubMed CrossRef
  51.Baysal T, Mutlu DY, Yologlu S (2009) Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma. Magn Reson Imaging 27:1447–1454PubMed CrossRef
  52.Sinkus R, Van Beers BE, Vilgrain V, DeSouza N, Waterton JC (2012) Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development. Eur J Cancer 48:425–431PubMed CrossRef
  53.Baba S, Isoda T, Maruoka Y et al (2014) Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging. J Nucl Med 55:736–742PubMed CrossRef
  54.Thormer G, Otto J, Reiss-Zimmermann M et al (2012) Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol 22:1820–1828PubMed CrossRef
  55.Kuang F, Ren J, Zhong Q, Liyuan F, Huan Y, Chen Z (2013) The value of apparent diffusion coefficient in the assessment of cervical cancer. Eur Radiol 23:1050–1058PubMed CrossRef
  56.Santos MK, Elias J Jr, Mauad FM, Muglia VF, Trad CS (2011) Magnetic resonance imaging of the chest: current and new applications, with an emphasis on pulmonology. J Bras Pneumol 37:242–258PubMed CrossRef
  57.Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC (2007) Small cell lung cancer: have we made any progress over the last 25 years? Oncologist 12:1096–1104PubMed CrossRef
  58.Collins LG, Haines C, Perkel R, Enck RE (2007) Lung cancer: diagnosis and management. Am Fam Physician 75:56–63PubMed
  59.Yabuuchi H, Murayama S, Sakai S et al (1999) Resected peripheral small cell carcinoma of the lung: computed tomographic-histologic correlation. J Thorac Imaging 14:105–108PubMed CrossRef
  60.Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA (2004) Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 22:3248–3254PubMed CrossRef
  61.Delgado PI, Jorda M, Ganjei-Azar P (2000) Small cell carcinoma versus other lung malignancies: diagnosis by fine-needle aspiration cytology. Cancer 90:279–285PubMed CrossRef
  62.Mazzone P, Jain P, Arroliga AC, Matthay RA (2002) Bronchoscopy and needle biopsy techniques for diagnosis and staging of lung cancer. Clin Chest Med 23:137–158. ix
  63.Desprechins B, Stadnik T, Koerts G, Shabana W, Breucq C, Osteaux M (1999) Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses. AJNR Am J Neuroradiol 20:1252–1257PubMed
  64.Kwee TC, Takahara T, Ochiai R et al (2010) Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications. J Nucl Med 51:1549–1558PubMed CrossRef
  65.Wang J, Takashima S, Takayama F et al (2001) Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 220:621–630PubMed CrossRef
  66.Partridge SC, Mullins CD, Kurland BF et al (2010) Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 194:1664–1673PubMed CrossRef
  
• 作者单位：Guohua Shen (1)
  Zhiyun Jia (1)
  Houfu Deng (1)
  
  1. Department of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, Sichuan, 610041, People’s Republic of China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Imaging and Radiology
  Diagnostic Radiology
  Interventional Radiology
  Neuroradiology
  Ultrasound
  Internal Medicine
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-1084

文摘

Objectives The potential performance of apparent diffusion coefficient (ADC) values for distinguishing malignant and benign pulmonary lesions, further characterizing the subtype of lung cancer was assessed.